These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6261269)

  • 21. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
    Lawrence DK; Pertwee RG
    Br J Pharmacol; 1973 Oct; 49(2):373-5. PubMed ID: 4793443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Pharmacology; 1996 May; 52(5):271-82. PubMed ID: 8807671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
    Freedland CS; Whitlow CT; Miller MD; Porrino LJ
    Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Δ⁹-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar rats.
    Taffe MA; Creehan KM; Vandewater SA; Kerr TM; Cole M
    Exp Clin Psychopharmacol; 2021 Feb; 29(1):1-13. PubMed ID: 32297788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-tolerance between delta9-tetrahydrocannabinol and ethanol: the role of drug disposition.
    Siemens AJ; Doyle OL
    Pharmacol Biochem Behav; 1979 Jan; 10(1):49-55. PubMed ID: 441094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of experience in acquisition and loss of tolerance to the effect of delta-9-THC on spaced responding.
    Manning FJ
    Pharmacol Biochem Behav; 1976 Sep; 5(3):269-73. PubMed ID: 996059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol.
    Hutcheson DM; Tzavara ET; Smadja C; Valjent E; Roques BP; Hanoune J; Maldonado R
    Br J Pharmacol; 1998 Dec; 125(7):1567-77. PubMed ID: 9884086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional interaction and cross-tolerance between ethanol and Δ9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors.
    Dar MS
    Behav Brain Res; 2014 Aug; 270():287-94. PubMed ID: 24875771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
    Hayakawa K; Mishima K; Nozako M; Ogata A; Hazekawa M; Liu AX; Fujioka M; Abe K; Hasebe N; Egashira N; Iwasaki K; Fujiwara M
    Neuropharmacology; 2007 Mar; 52(4):1079-87. PubMed ID: 17320118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time course for the induction and maintenance of tolerance to Delta(9)-tetrahydrocannabinol in mice.
    Bass CE; Martin BR
    Drug Alcohol Depend; 2000 Aug; 60(2):113-9. PubMed ID: 10940538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance to the effects of delta9-THC on shuttle-box performance and body temperature.
    ten Ham M
    Pharmacol Biochem Behav; 1977 Feb; 6(2):183-5. PubMed ID: 859896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profound hypothermia in mammals treated with tetrahydrocannabinols, morphine, or chlorpromazine.
    Haavik CO
    Fed Proc; 1977 Nov; 36(12):2595-8. PubMed ID: 913617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
    Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
    J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of tolerance to immunosuppressive activity of delta 9-tetrahydrocannabinol in rats.
    Luthra YK; Esber HJ; Lariviere DM; Rosenkrantz H
    J Immunopharmacol; 1980; 2(2):245-56. PubMed ID: 6101114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
    Zuardi AW; Karniol IG
    Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
    Wakley AA; Wiley JL; Craft RM
    Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of chronic administration of delta 9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in freely moving rats.
    Kawasaki H; Watanabe S; Ueki S
    Eur J Pharmacol; 1980 Jul; 65(1):63-9. PubMed ID: 6249621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta9 -tetrahydrocannabinol increases brain temperature and inverts circadian rhythms.
    Perron RR; Tyson RL; Sutherland GR
    Neuroreport; 2001 Dec; 12(17):3791-4. PubMed ID: 11726796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin's reinforcing efficacy: a self-administration study in rats.
    Solinas M; Panlilio LV; Goldberg SR
    Neuropsychopharmacology; 2004 Jul; 29(7):1301-11. PubMed ID: 15039767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.